Citation 80067

MIMAKI,Y: KURODA,M: KAMEYAMA,A: YOKOSUKA,A: SASHIDA,Y:. (1998). NEW STEROIDAL CONSTITUENTS OF THE UNDERGROUND PARTS OF RUSCUS ACULEATUS AND THEIR CYTOSTATIC ACTIVITY ON HL-60 CELLS.. 46(2)

Citation Details

TitleNEW STEROIDAL CONSTITUENTS OF THE UNDERGROUND PARTS OF RUSCUS ACULEATUS AND THEIR CYTOSTATIC ACTIVITY ON HL-60 CELLS.
AuthorsMIMAKI,Y: KURODA,M: KAMEYAMA,A: YOKOSUKA,A: SASHIDA,Y:
Year1998
Volume46
Issue2

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Ruscus aculeatus (LILIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
RUSCOGENIN,NEO: 1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-ALPHA-L-ARABINOPYRANOSIDE]
None
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
RUSCOGENIN,NEO: 1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-ALPHA-L-ARABINOPYRANOSIDE]
WEAK ACTIVITY
3Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
FUROSTA-5-25(27)-DIENE-1-BETA-3-BETA-22-ZETA-26-TETROL-1-O-[ALPHA-L-RHAMNOPYRANOSYL-(1-2)-ALPHA-L-ARABINOPYRANOSIDE]26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL:
None
4Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
RUSCOGENIN,NEO: 1-O-[O-BETA-D-GLUCOPYRANOSYL-(1-2)-ALPHA-L-ARABINOPYRANOSIDE
None
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FUROSTA-5-25(27)-DIENE-1-BETA-3-BETA-22-ZETA-26-TETROL-1-O-[ALPHA-L-RHAMNOPYRANOSYL-(1-2)-ALPHA-L-ARABINOPYRANOSIDE]26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL:RUSCOGENIN,NEO: 1-O-[O-BETA-D-GLUCOPYRANOSYL-(1-2)-ALPHA-L-ARABINOPYRANOSIDE
EQUIVOCAL
6Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
FUROSTA-5-25(27)-DIENE-1-BETA-3-BETA-22-ZETA-26-TETROL-1-O-[O-BETA-D-GLUCOPYRANOSYL-(1-3)-O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-ALPHA-L-ARABINOPYRANOSIDE]26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL:
None
7Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
FUROSTA-5-25(27)-DIENE-1-BETA-3-BETA-22-ZETA-26-TETROL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-O-BETA-D-XYLOPYRANOSYL-(1-3)]-ALPHA-L-ARABINOPYRANOSIDE],26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL:
None
8
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FUROSTA-5-25(27)-DIENE-1-BETA-3-BETA-22-ZETA-26-TETROL-1-O-[O-BETA-D-GLUCOPYRANOSYL-(1-3)-O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-ALPHA-L-ARABINOPYRANOSIDE]26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL:FUROSTA-5-25(27)-DIENE-1-BETA-3-BETA-22-ZETA-26-TETROL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-O-BETA-D-XYLOPYRANOSYL-(1-3)]-ALPHA-L-ARABINOPYRANOSIDE],26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL:
EQUIVOCAL
9Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
RUSCOGENIN,NEO: 1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-4-O-SULFO-ALPHA-L-ARABINOPYRANOSIDE
None
10Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
FUROSTA-5-25(27)-DIENE-1-BETA-3-BETA-22-ZETA-26-TETROL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-4-O-SULFO-ALPHA-L-ARABINOPYRANOSIDE],26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL:
None
11
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
RUSCOGENIN,NEO: 1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-4-O-SULFO-ALPHA-L-ARABINOPYRANOSIDEFUROSTA-5-25(27)-DIENE-1-BETA-3-BETA-22-ZETA-26-TETROL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-4-O-SULFO-ALPHA-L-ARABINOPYRANOSIDE],26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL:
EQUIVOCAL
12Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
FUROSAT-5-25(27)-DIENE-1-BETA-3-BETA-22-ZETA-26-TETROL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-3-O-ACETYL-4-O-SULFO-ALPHA-L-ARABINOPYRANOSIDE],26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL:
None
13Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
FUROSTA-5-25(27)-DIENE-1-BETA-3-BETA-22-ZETA-26-TETROL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-3-O-ACETYL-4-O-[2(S)-3(S)-2-HYDROXY-3-METHYL-PENTANOYL]-ALPHA-L-ARABINOPYRANOSIDE,26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL:
None
14
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FUROSAT-5-25(27)-DIENE-1-BETA-3-BETA-22-ZETA-26-TETROL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-3-O-ACETYL-4-O-SULFO-ALPHA-L-ARABINOPYRANOSIDE],26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL:
INACTIVE
15
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FUROSTA-5-25(27)-DIENE-1-BETA-3-BETA-22-ZETA-26-TETROL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-3-O-ACETYL-4-O-[2(S)-3(S)-2-HYDROXY-3-METHYL-PENTANOYL]-ALPHA-L-ARABINOPYRANOSIDE,26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL:
ACTIVE
16Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
RUSCOGENIN,NEO: 1-O[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-3-O-ACETYL-4-O-(2(S)-3(S)-2-HYDROXY-3-METHYL-PENTANOYL]-ALPHA-L-ARABINOPYRANOSIDE
None
17Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
FUROSTA-5-25(27)-DIENE-1-BETA-3-BETA-22-ZETA-26-TETROL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)4-O-ACETYL-ALPHA-L-ARABINOPYRANOSIDE],26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL:
None
18
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
RUSCOGENIN,NEO: 1-O[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-3-O-ACETYL-4-O-(2(S)-3(S)-2-HYDROXY-3-METHYL-PENTANOYL]-ALPHA-L-ARABINOPYRANOSIDE
ACTIVE
19
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FUROSTA-5-25(27)-DIENE-1-BETA-3-BETA-22-ZETA-26-TETROL-1-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)4-O-ACETYL-ALPHA-L-ARABINOPYRANOSIDE],26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL:
WEAK ACTIVITY
20Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
RUSCOGENIN,NEO: 1-O-[O-BETA-D-GLUCOPYRANOSYL-(1-3)-O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-4-O-ACETYL-ALPHA-L-ARABINOPYRANOSIDE
None
21
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
RUSCOGENIN,NEO: 1-O-[O-BETA-D-GLUCOPYRANOSYL-(1-3)-O-ALPHA-L-RHAMNOPYRANOSYL-(1-2)-4-O-ACETYL-ALPHA-L-ARABINOPYRANOSIDE
WEAK ACTIVITY
Show SPARQL Queries (1)